Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Clin Exp Dermatol ; 45(2): 207-211, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31361915

ABSTRACT

We describe two patients with BRAF-mutated melanoma of the epithelioid cell type arising from primary acquired melanosis with severe atypia of the right bulbar conjunctiva. Patient 1 was a 71-year-old Japanese man. After adjuvant cryotherapy and enucleation of the right eyeball, therapy with vemurafenib was administered for a distant metastasis to a lumbar vertebra, accompanied by erythema multiforme and two keratinous tumours. The patient died due to metastases to the liver and multiple vertebrae, despite therapy with nivolumab and combination therapy with dabrafenib plus trametinib. Patient 2 was a 72-year-old Japanese man. After adjuvant cryotherapy, periodic mitomycin C eye drops, and excision of the superficial portion of the right parotid gland and the dissection of cervical lymph nodes, he was treated with adjuvant combination therapy with dabrafenib plus trametinib. Dermatologists should be familiar with BRAF-mutated conjunctival melanoma, which is usually located on the bulbar conjunctiva and associated with more frequent distant metastasis.


Subject(s)
Conjunctival Neoplasms/genetics , Melanoma/genetics , Mutation , Proto-Oncogene Proteins B-raf/genetics , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Conjunctiva/pathology , Conjunctiva/surgery , Conjunctival Neoplasms/pathology , Conjunctival Neoplasms/therapy , Fatal Outcome , Humans , Liver Neoplasms/secondary , Lymphatic Metastasis , MAP Kinase Kinase Kinases/antagonists & inhibitors , Male , Melanoma/pathology , Melanoma/secondary , Melanoma/therapy , Protein Kinase Inhibitors/therapeutic use , Proto-Oncogene Proteins B-raf/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL